Dec. 21, 2017 Price forecast | 2 weeks: 0.79% | 1 month: 0.95% | 3 months: 3.67%


PRPH stock forecast

Our latest prediction for ProPhase Labs, Inc.'s stock price was made on the Dec. 21, 2017 when the stock price was at 2.20$.

In the short term (2weeks), PRPH's stock price should outperform the market by 0.79%. During that period the price should oscillate between -6.29% and +10.93%.

In the medium term (3months), PRPH's stock price should outperform the market by 3.67%. During that period the price should oscillate between -13.59% and +26.70%.


About ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products and dietary supplements. Its products include TK supplement. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Doylestown, PA.

At the moment the company generates 13M USD in revenues.

On its last earning announcement, the company reported a profit of 0.13$ per share.

The book value per share is 1.78$

ProPhase Labs, Inc. website


Three months stock forecastDec. 21, 2017


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
13M 35.90% -2M -11.80% - 0.13 - - 12M 1.78 -3M - -3M